Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1979-1-15
|
pubmed:abstractText |
Three patients treated with nafcillin developed granulocytopenia. Only three other such cases have been reported. This complication is most likely due to a direct toxic effect on the bone marrow; markers for an immunologically mediated mechanism have not been found. Nafcillin-associated granulocytopenia usually occurs during the third week of therapy and remits spontaneously with prompt cessation of nafcillin administration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0038-4348
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1356-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:715483-Adolescent,
pubmed-meshheading:715483-Agranulocytosis,
pubmed-meshheading:715483-Female,
pubmed-meshheading:715483-Humans,
pubmed-meshheading:715483-Male,
pubmed-meshheading:715483-Middle Aged,
pubmed-meshheading:715483-Nafcillin,
pubmed-meshheading:715483-Remission, Spontaneous,
pubmed-meshheading:715483-Time Factors
|
pubmed:year |
1978
|
pubmed:articleTitle |
Nafcillin-associated granulocytopenia.
|
pubmed:publicationType |
Journal Article,
Case Reports
|